BCL2-Like 11 (Apoptosis Facilitator) (BCL2L11) (pSer69,pSer65) antibody
| Antigen | BCL2-Like 11 (Apoptosis Facilitator) (BCL2L11) |
| Synonyms | BAM, BIM, BOD, BimL, BimEL, BIM-beta6, BIM-beta7, BIM-alpha6, Bim, Bod, 1500006F24Rik, bim |
| Binding Site |
Alternatives pSer69,pSer65 |
| Host |
Alternatives Rabbit |
| Reactivity |
Alternatives Human, Mouse (Murine), Rat (Rattus) |
| Conjugate |
Alternatives Un-conjugated |
| Application |
Alternatives Immunohistochemistry (IHC) |
![]() |
2 references available |
| Catalog no. | ABIN965668 |
| Quantity | 100ug (100ug/100ul.) |
| Price | 385.00 $ Plus shipping costs $45.00 |
| Shipping to |
|
| Availability | Will be delivered in 5 to 7 Business Days |
Additional Information
| Alternative name | BIM |
| Immunogen | The antiserum was produced against synthesized phosphopeptide derived from human BIM around the phosphorylation site of serine 69 (P-A-SP-P-G). |
| Specificity | BIM (phospho-Ser69/65) antibody detects endogenous levels of BIM only when phosphorylated at serine 69/65. |
Application Details
| Application Notes | IHC: 1:50-1:100. |
| Concentration | 100ug/100ul. |
| Purification | The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific phosphopeptide. The antibody against non-phosphopeptide was removed by chromatography using nonphosphopeptide corresponding to the phosphorylation site. |
| Buffer | Rabbit IgG in phosphate buffered saline (without Mg2+ and Ca2+), pH 7.4, 150mM NaCl, 50% glycerol |
| Preservative | 0.02% Sodium Azide |
| Storage | Store at -20°C/1 year. |
| Restrictions | For Research Use only |
Publications
| Product |
Luciano, Jacquel, Colosetti et al.: "Phosphorylation of Bim-EL by Erk1/2 on serine 69 promotes its degradation via the proteasome pathway and regulates its proapoptotic function." in: Oncogene, Vol. 22, Issue 43, pp. 6785-93, 2003 (PubMed).
Fukazawa, Noguchi, Masumi et al.: "BimEL is an important determinant for induction of anoikis sensitivity by mitogen-activated protein/extracellular signal-regulated kinase kinase inhibitors." in: Molecular cancer therapeutics, Vol. 3, Issue 10, pp. 1281-8, 2004 (PubMed). |
Alternatives
Alternatives for antigen "BCL2-Like 11 (Apoptosis Facilitator) (BCL2L11)", type "Antibodies"




Alternatives